Page last updated: 2024-08-23

tetradecanoylphorbol acetate and Huntington Disease

tetradecanoylphorbol acetate has been researched along with Huntington Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nukina, N; Zemskov, EA1
Birdsall, M; Coles, R; Rubinsztein, DC; Wyttenbach, A1

Other Studies

2 other study(ies) available for tetradecanoylphorbol acetate and Huntington Disease

ArticleYear
Impaired degradation of PKCalpha by proteasome in a cellular model of Huntington's disease.
    Neuroreport, 2003, Aug-06, Volume: 14, Issue:11

    Topics: Animals; Cell Membrane; Cysteine Endopeptidases; Cytosol; Down-Regulation; Electrophoresis, Polyacrylamide Gel; Humans; Huntington Disease; Mice; Multienzyme Complexes; Mutation; Neuroblastoma; Precipitin Tests; Proteasome Endopeptidase Complex; Protein Kinase C; Protein Kinase C-alpha; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Ubiquitin

2003
12-O-tetradecanoyl-phorbol-13-acetate down-regulates the Huntingtin promoter at Sp1 sites.
    Neuroreport, 2000, Sep-28, Volume: 11, Issue:14

    Topics: Chromosome Mapping; Down-Regulation; Gene Expression Regulation; HeLa Cells; Humans; Huntingtin Protein; Huntington Disease; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Promoter Regions, Genetic; Tetradecanoylphorbol Acetate; Transcription, Genetic; Tumor Cells, Cultured

2000